EUVIMEDEUVIMED entdecken
Leserbrief

Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience

Maddalena Napolitano, Luca Potestio iD, Katharina Hansel, Rossella Marietti, Ilaria Piscitelli, Gabriella Fabbrocini, Luca Stingeni, Cataldo Patruno

Clinical and Experimental Dermatology · 2023

DOI: 10.1093/ced/llac078 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Maddalena Napolitano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansAdultHeterocyclic Compounds, 3-RingTreatment OutcomeSeverity of Illness IndexDouble-Blind Method

Substanzen

upadacitinibHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
  • Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II.
  • Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.

ORCID-Profile: Luca Potestio

Zitieren

APA

Napolitano, M., Potestio, L., Hansel, K., Marietti, R., Piscitelli, I., Fabbrocini, G., Stingeni, L., & Patruno, C. (2023). Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llac078

Vancouver

Napolitano M, Potestio L, Hansel K, Marietti R, Piscitelli I, Fabbrocini G, et al. Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llac078

BibTeX
@article{Napolitano2023,
  author = {Napolitano, Maddalena and Potestio, Luca and Hansel, Katharina and Marietti, Rossella and Piscitelli, Ilaria and Fabbrocini, Gabriella and Stingeni, Luca and Patruno, Cataldo},
  title = {Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience},
  journal = {Clinical and Experimental Dermatology},
  year = {2023},
  doi = {10.1093/ced/llac078}
}
Kostenlos starten →